Wednesday · October 7, 2026
Investigational

Scientists Reviewed 20 Medicinal Mushrooms to Find the Best Gut Boosters

A new scientific review looked at 20 edible and medicinal fungi, including reishi, shiitake and cordyceps, to map how their polysaccharides feed gut bacteria and what that could mean for gut health, with human trials still needed.

Scientists Reviewed 20 Medicinal Mushrooms to Find the Best Gut Boosters

If you've wondered whether that reishi tea or shiitake soup does anything for your gut beyond flavor, a new review gives the clearest answer yet: many medicinal and culinary mushrooms contain carbohydrates that your gut bacteria can use as fuel. Researchers combed through the existing evidence on 20 different fungal species, from reishi and shiitake to lesser-known species used in traditional medicine, to map which of their compounds act like prebiotics (fibers that feed beneficial gut microbes) rather than just passing through. For anyone managing a gut-related condition and looking for lower-risk ways to support their microbiome, the findings offer a useful, if still early-stage, roadmap.

Key takeaways

  • A review of 20 edible and medicinal fungi found their polysaccharides (complex carbohydrates built from chains of sugar molecules) resist digestion in the stomach and small intestine and reach the colon intact.
  • Once there, gut bacteria ferment them into short-chain fatty acids, including butyrate, and the fermentation boosted beneficial genera like Bifidobacterium, Lactobacillus, and Akkermansia while reducing Desulfovibrio, a bacterium linked to gut inflammation.
  • Species reviewed included reishi (Ganoderma lucidum), shiitake (Lentinus edodes), Poria cocos, king oyster mushroom (Pleurotus eryngii), and cordyceps (Cordyceps militaris).
  • The evidence so far comes almost entirely from lab and animal studies, not human trials, so no mushroom or extract should be treated as a proven gut-health fix yet.

20 Medicinal Mushrooms Reviewed for Their Gut-Feeding Polysaccharides

Researchers, led by Zheng and colleagues and published August 27, 2026 in npj Science of Food, reviewed 20 verified, non-toxic edible and medicinal fungal species, including reishi (Ganoderma lucidum), shiitake (Lentinus edodes), Poria cocos, king oyster mushroom (Pleurotus eryngii), and cordyceps (Cordyceps militaris), to catalog how their polysaccharides interact with the gut. The molecules varied widely in size, from a few thousand daltons (a unit of molecular weight) up to several million, and were typically built from sugar units including glucose, galactose, mannose, xylose, and fucose. Taxonomically, 95% of the species reviewed belonged to the fungal class Agaricomycetes, and 15% belonged to the family Polyporaceae, a group known for producing especially complex, digestion-resistant polysaccharides.

Why This Matters for People Managing Gut-Related Conditions

Because polysaccharide fermentation directly reshapes the gut's bacterial balance, this research is most relevant to people already managing a condition tied to that balance, including IBS, IBD, and metabolic issues like insulin resistance. The review found that fermentation of these mushroom compounds by gut bacteria consistently produced short-chain fatty acids, acetate, propionate, butyrate, and isovalerate, compounds that feed the cells lining the colon and help regulate inflammation, as detailed in a broader review of short-chain fatty acids and host health. Across the fungi studied, fermentation also tended to raise levels of Bifidobacterium, Lactobacillus, and Akkermansia, a genus separately linked in a review of Akkermansia muciniphila to improved gut barrier function and metabolic health, while lowering Desulfovibrio, a sulfate-reducing bacterium associated with gut inflammation.

How the Review Pulled Evidence From 20 Separate Fungal Species

This wasn't a single new experiment; it was a literature review that synthesized structural analyses and existing fermentation studies published on each of the 20 fungal species, comparing their polysaccharide structures side by side to identify patterns linking molecular structure to microbial effects. That approach lets researchers spot which structural features, like branching pattern or sugar composition, most consistently predict a prebiotic effect, but it also means the strength of evidence varies species by species, since some fungi have been studied far more than others. A separate corroborating review of edible mushrooms as prebiotic sources reached similar conclusions about polysaccharide structure driving gut microbial shifts.

What This Could Mean If You're Managing Your Own Gut Health

For a reader already tracking their gut symptoms, the practical takeaway is modest: whole mushrooms like shiitake and reishi, whether cooked into food or brewed as tea, contain these polysaccharides naturally, but this review does not establish a specific human dose, a guaranteed effect, or which condition would benefit most. It is not evidence that any mushroom supplement treats or reverses a diagnosed digestive or autoimmune condition. Concentrated extracts, especially reishi and cordyceps products sold as supplements, can also interact with medications or affect blood clotting, so anyone considering them, particularly alongside an existing gut or immune condition, should raise it with a doctor first rather than self-prescribing based on this review.

The Evidence Gap Between Lab Dishes and Human Guts

The review's own authors flagged the central limitation plainly: most of the evidence still comes from in vitro (test tube or lab dish) experiments and animal studies, not human clinical trials. That gap matters because gut fermentation, transit time, and existing microbiome composition all differ between a lab simulation, a mouse, and an actual person, so an effect seen in a petri dish or a rodent does not automatically translate to a measurable benefit in humans.

What Comes Next for Mushroom-Based Prebiotics

The logical next step, and the one the review calls for directly, is human clinical trials that test whether these polysaccharides, isolated or as whole foods, actually shift gut bacteria and produce measurable health outcomes in people, not just cells or animals. Standardizing how these compounds are extracted and dosed would also need to happen before any of the 20 species reviewed could reasonably move from traditional-medicine status to an evidence-backed supplement.

Common Questions

Are reishi and shiitake mushrooms good for gut health? Lab evidence suggests their polysaccharides can be fermented by gut bacteria into beneficial byproducts like short-chain fatty acids, but no human trials in this review confirmed a specific health benefit from eating them.

What are polysaccharides and why do they matter for gut bacteria? They are complex carbohydrates built from chains of sugar molecules; because the human gut cannot fully digest many of them, they reach the colon intact, where bacteria ferment them into compounds like butyrate.

Should I take a medicinal mushroom supplement for my gut? Not based on this review alone. It did not test supplements in people, so there is no established human dose or proven benefit, and some mushroom extracts can interact with medications, so check with a doctor first.

What's the difference between prebiotics and probiotics? Probiotics are live bacteria you consume directly; prebiotics, like these mushroom polysaccharides, are food sources that feed the beneficial bacteria already living in your gut.

Evidence Rating

INVESTIGATIONAL — 80/100

Caveats

  • Evidence is drawn from in vitro and animal studies, not human clinical trials, per the review’s own authors.
  • This is a review synthesizing prior literature on 20 species, not a single new controlled experiment.
  • Findings do not establish a proven human dose, supplement, or treatment for any specific gut condition.

This is a literature review synthesizing existing structural and fermentation data on 20 edible/medicinal fungal species, not a new human clinical trial. It compiles largely in vitro and animal-model evidence that fungal polysaccharides resist digestion and are fermented by gut bacteria into SCFAs, shifting select bacterial genera. No human trial data was reported.

References

  1. Ruli Zheng, Tianjing Wang, Lin Bai, et al. (2026). Medicinal and edible fungal polysaccharide: sources, preparation, structural characteristics, and health benefits. npj Science of Food. https://doi.org/10.1038/s41538-026-01092-z
  2. Kallie E. Hays, Jacob M. Pfaffinger, Rebecca Ryznar (2024). The interplay between gut microbiota, short-chain fatty acids, and implications for host health and disease. Gut Microbes. https://doi.org/10.1080/19490976.2024.2393270
  3. Ezinne Aja, Amber Zeng, Weston Gray, Kaden Connelley, Anil Chaganti, Jonathan P. Jacobs (2025). Health Effects and Therapeutic Potential of the Gut Microbe Akkermansia muciniphila. Nutrients. https://doi.org/10.3390/nu17030562